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esponsibility of InstAbstract Sodium humate (HA-Na) has been topically used as a wound healing and anti-inﬂammatory
agent in folk medicine. In the present study, HA-Na was investigated for cutaneous wound healing in
Sprague–Dawley rats. HA-Na solution (1.0%, w/v) was topically administered to rats undergoing excision
wound models. Healing was assessed with a recombinant bovine basic ﬁbroblast growth factor for
external use as positive control. Wound healing rates were calculated on Day 3, 6, 9, 14 and 21 after
injury, and tissues were also harvested after the same intervals for histological analysis. In addition, tissue
hydroxyproline levels were measured. Furthermore, mRNA levels and protein expressions of transforming
growth factor-β1, 2, 3 (TGF-β1, 2, 3) were determined by RT-PCR and western blot. Protein expression
levels of Smad-2, -3, -4 and -7 were also detected by western blot. Our study demonstrates that HA-Na
has the capacity to promote wound healing in rats via accelerated wound contraction and increased
hydroxyproline content. More importantly, these wound healing effects of HA-Na might be mediated
through the TGF-β/Smad signaling pathway. HA-Na may be an effective agent for enhanced wound
healing.
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Over the past several years, research on medicinal properties of
natural products has increased signiﬁcantly, and a large body of
evidence suggests extracts from peat and sapropel may represent a
source of novel compounds with medicinal properties1–4. Humic
substances have been used traditionally in folk medicine for
treatment of a variety of disorders, including colitis and Alzhei-
mer's disease5,6. Humic acid originates from a class of humic
substances via chemical and/or biochemical degradation. It is not a
single acid; rather, it is a complex mixture of many different acids
containing carboxyl and phenolate groups. Humic acid has been
utilized in traditional Chinese medicine (TCM) and possesses
various pharmacological properties. Sodium humate (HA-Na) is
salt of humic acid and has been used therapeutically for centuries
as part of traditional systems of medicine in many countries.
Especially, HA-Na has been traditionally applied for the medicinal
practice over thousands of years in China. HA-Na, a potent anti-
inﬂammatory, anti-microbial, antivirus, antitumor and anti-ulcer
drug, has been used as a treatment for immunoregulation,
endocrine regulation and other diseases.
Wound healing is a complicated process involving different
phases of inﬂammation, new tissue formation and remodeling7.
These phases are not distinct, but form a continuous wound
healing process. Wound healing is a response to injury aiming at
reconstructing damaged tissue and requires precise coordination of
connective tissue repair, re-epithelialization, and angiogenesis8. In
many developed country, several growth factors have been used
for wound healing. Currently, patients are treated by three growth
factors: platelet-derived growth factor-BB (PDGF-BB), basic
ﬁbroblast growth factor (bFGF), and granulocyte-macrophage
colony-stimulating factor (GM-CSF), but the cost of this therapy
is high in developing countries9. Burn trauma and wounds are still
a major problem in developing countries, often having severe
complications and involving high costs for therapy. The use of
TCM in treating burns and wounds is an important mode to
improve healing, as well as to reduce the ﬁnancial burden. In
China, several plants and herbs have been experimentally used as
traditional medicine to treat skin disorders and wound injuries10–
13. HA-Na is also used as anti-inﬂammatory, hemostatic, antidiar-
rheal, and anti-rheumatic agents and it has been a unique drug
treatment of trauma in many Chinese hospitals for many years. At
present, however, controlled studies of the effect of HA-Na on
wound healing are lacking.
The wound healing activity of HA-Na was presently determined
in rats to explore the efﬁcacy and possible mechanisms of action to
rationalize its traditional use.2. Materials and methods
2.1. Drugs and reagents
HA-Na sample was purchased from Institute of Coal Chemistry,
Chinese Academy of Sciences (Taiyuan, China). The components
of HA-Na consist of 14.22% water (air dry basis), 23.34% burning
residue (dry basis), 73.33% humic acid (dry basis) and 4.48%
water soluble substances (dry basis) according to analysis report of
the product. Recombinant bovine basic ﬁbroblast growth factor
(rb-bFGF) for external use was purchased from Zhuhai YiSheng
biological pharmaceutical Co., Ltd. (Zhuhai, China). Hydroxypro-
line detection kit (alkaline hydrolysis method) was purchased fromNanjing Jiancheng Bioengineering Institute (Nanjing, China). Gel
preparation kit (Tris–HCl, SDS, TEMED, AP), phenylmethane-
sulfonyl ﬂuoride, glycine, nitrocellulose membrane, primary/sec-
ondary antibodies and western blot ECL chromogenic detection kit
were purchased from Wuhan boster biological engineering Co.,
Ltd. (Wuhan, China). CD31 primary antibody was from Bioss
biological engineering Co., Ltd. (Beijing, China). Biotin-
streptavidin HRP detection systems were purchased ZSGB biolo-
gical engineering Co., Ltd. (Beijing, China). All other chemicals
and reagents were of analytical grade.
2.2. Experimental animals
Male Sprague–Dawley rats (SPF, weight 200–250 g) were pur-
chased from the Experimental Animal Center of Xi'an Jiaotong
University School of Medicine (Xi'an, China). The animals were
housed under controlled conditions (12 h/12 h light/dark cycle,
22–28 1C and 60%–70% air humidity), fed with normal mice
chow and water ad libitum. All animals were acclimated for at
least 3 days prior to the ﬁrst treatment. The rats were anesthetized
before and during inﬂiction of the experimental wounds. The
surgical interventions were carried out under sterile conditions
using 10% chloral hydrate anesthesia (300 mg/kg, i.p.). All
experimental procedures carried out in this study were approved
by the Ethics Committee of School of Medicine, Xi'an Jiaotong
University and were in accordance with the US Guidelines for the
Care and Use of Laboratory Animals (NIH publication #85-23,
revised in 1985).
2.3. Wound creation and treatment
The rats were weighed before the experiment and anaesthetized
prior to and during inﬂiction of the experimental wounds. The rats
were inﬂicted with excision wounds as described by Arunachalam
et al.14 and Ganeshkumar et al.15. Brieﬂy, the rats were anesthe-
tized, the dorsal fur of the animal was shaved with an electric
clipper and the area of the wound to be created was outlined on the
back of the animals with methylene blue using a circular stainless
steel stencil. The depth of the wound was outlined by inserting a
ﬂexible device into the wound, making sure it is lined up
perpendicular to the edge of the wound. A full thickness of the
excision wound of 500 mm2 and 2 mm depth was created along
the markings using toothed forceps, a surgical blade and pointed
scissors. The rats were randomly divided into 3 groups. Group
1 was non-treated as a control group; group 2 was treated with
0.5 mL/cm2 rb-bFGF (4200 IU/mL) and served as a reference
standard (positive control); group 3 was treated topically with an
equal amount of 1.0% (w/v) HA-Na solution. Standard wound
cleansing was performed daily for all the groups prior to the
application of HA-Na or rb-bFGF. HA-Na or rb-bFGF were
topically applied twice daily for 14 days. Epithelialization was
considered to have occurred when the eschar fell off without
leaving any residual raw wound. Any rat showing signs of
infection was excluded and sacriﬁced with a 10% chloral hydrate
overdose.
The wound closure rate was assessed by tracing the wound on
Day 3, 6, 9, 14 and 21 post-wounding with transparency paper and
a permanent marker. The wound areas recorded were measured
using a graph paper16. Time to wound closure was deﬁned when
the wound bed was completely re-epithelialized and ﬁlled with
new tissue. The wounding day was considered as Day 0. The
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tion of the original wound size (Day 0). The wound healing rate
was calculated with a formula as following:
Percentage wound contractionð%Þ ¼ ½ðA0–AnÞ=A0   100 ð1Þ
where An is the wound area on Day n, and A0 is the wound area on
Day 017.
For histopathological studies and biochemical analyses, the
wounds together with a uniform perimeter of surrounding tissue
(excluding any underlying muscle and extraneous tissue) were
harvested on Day 3, 6, 9, 14 and 21 following wounding. A
portion of harvested tissue was immediately stored in liquid
nitrogen for further analysis and another portion was ﬁxed in
4% formaldehyde for histopathological study.
2.4. Histopathological evaluation
Tissues from the wound site after treatment with HA-Na solution, rb-
bFGF and untreated control were removed after sacriﬁce and ﬁxed in
4% formaldehyde, dehydrated through a series of alcohol, cleared in
xylene and embedded in parafﬁn wax. Five mm thick sections, which
were harvested on Day 6 and 14 post-wounding, stained with
hematoxylin–eosin (HE) and Masson's trichrome (MT), and observed
and photographed under light microscopy. Immunohistochemical
staining for CD31 was carried out on control group, bFGF group,
and 1.0% HA-Na group postoperatively on Day 6 and 14. Brown dots
present in images of endothelial cells indicated positive staining. Six
random, unrepeated ﬁelds were selected for observation (400 ). The
number of newly grown microvessels (brown staining) was calculated
using Image-Pro Plus 6.0 according to the conversion of each vision
ﬁeld area of 0.1885 mm2 being equal to 1 mm2. An average of
6 replicates was recorded as the microvessel density (MVD)18.
2.5. Hydroxyproline assay
Tissue hydroxyproline levels were measured on Day 3, 6, 9, 14
and 21 post-injury using hydroxyproline detection kit according to
the manufacturer's protocol.
2.6. RNA extraction and RT-PCR analysis
The expression patterns of Tgf-β1, Tgf-β2 and Tgf-β3 of wounded
tissue on the 6th and 14th days post-wounding were analyzed by
RT-PCR. The total RNA content was isolated according to the
manufacturer's instruction (guanidine thiocyanate phenol, chloro-
form procedure, total RNA isolation kit, FSATGEN biological
technology Co., Ltd., Shanghai, China). Reverse transcription
reactions were performed in an GeneAmp PCR System (Applied
Biosystems, CA, USA) following manufacturer's guidelines
(Revert Aid TM First Strand cDNA Synthesis Kit, Canada).
Custom primers were created to Tgf-β1 (F5'-CT-
GAACCAAGGAGACGGAATAC-3', R5'-AACCCAGGTCCTTC
CTAAAGTC-3'), Tgf-β2 (F5'-AGGCAGAGTTCAGGGTCTTT
C-3', R5'- TGGCTCTTATTTGGGATGATG-3'), Tgf-β3 (5'-GAAG`
AGG GTGGAAGCCATTAG-3', R5'-GAGGACACATTGAAACG-
GAAA-3') and Gapdh (F5'-GCCTTCTCCATGGTGGTGAA-3', R5'-
GGTCGGTGTGAACGGATTTG-3') and obtained from Sangon Bio-
tech Co., Ltd. (Shanghai, China). Initial denaturing was performed at
94 1C for 3 min; then 40 cycles at 94 1C for 30 s (denaturing), at 53 1C
for Tgf-β1, Tgf-β2, Tgf-β3 and Gapdh for 30 s (annealing) and at 72 1C
for 1 min (extension) and a further extension at 72 1C for 5 min werecarried out. After ampliﬁcation, the RT-PCR products were electro-
phoresed on 2% agarose gel containing gethidium bromide.
Images were captured and subjected to densitometric analysis
using Bio-Rad Gel Doc™ XR gel documentation system equipped
with Image-ProPlus Software. The values were expressed as band
intensity of the target gene (Tgf-β1/Tgf-β2/Tgf-β3) relative to the
level of the reference mRNA for the housekeeping gene (Gapdh).
Three independent experiments were carried out to study mRNA
levels.
2.7. Western blot analysis
The harvested wound tissues were homogenized in a lysis buffer
containing 1% Triton X-100, 1% deoxycholate, 0.1% SDS and
1 mmol/L phenylmethylsulfonyl ﬂuoride (PMSF). The homogenate
was centrifuged at 12,000 r/pm for 10 min at 4 1C (Micro-21R,
Thermo Scientiﬁc, USA). The protein concentration was estimated
by the NanoDrop1000 (ND-1000, NanoDrop, USA). Equal amount of
protein was loaded on to the 10% SDS-PAGE with 5% stacking gel
wells and electrophoresed at 80 V for 25 min, and then 120 V for
45 min; thereafter, proteins were transblotted onto the NC membrane.
After blocking with blocking solution, the membranes were incubated
with TGF-β1, 2, 3, Smad-2, 3, 4, 7 and β-actin primary antibodies
(1:400) for overnight followed by 1 h incubation with secondary
antibodies (1:5000) on rocking shaker (ZHWY-100B, Shanghai
zhicheng, China) at 37 1C. The desired proteins were detected by
western blot ECL chromogenic detection kit. Optical densities of the
bands were scanned and quantiﬁed with the Syngene Gene Tools
(Syngene Corp., Cambridge, UK). Three independent experiments
were carried out to study protein expression.
2.8. Statistical analysis
The results are expressed as mean7SEM. Data were statistically
analyzed using one way analysis of variance (ANOVA) followed
by the Dunett test. A P-valueo0.05 was considered statistically
signiﬁcant as compared to control group.3. Results
3.1. Wound contraction and epithelialization period
The wound appeared clean and free of exudates throughout the study
in all the animal groups. Granulation tissue was evident at the wound
edges from Day 3 post-injury in all groups. The results of wound
contraction and epithelialization period after topical administration of
the HA-Na solution are reported in Table 1 and Fig. 1. Wound
contraction following 1.0% (w/v) HA-Na treatment was signiﬁcantly
greater (Po0.01) on Day 6, 9 and 14 as compared to the respective
control group. The epithelization period was also higher on the 14th
day in subjects treated with 1.0% HA-Na solution.
3.2. Histopathology
Well organized wound healing processes were observed following
treatment with either HA-Na solution or rb-bFGF. In haematoxylin
and eosin stained sections, wounds from the 1.0% (w/v) HA-Na
solution group showed more ﬁbroblasts, collagen ﬁbers, and
robust dermal blood vessel formation, with surrounding dense
and thick mesenchymal matrix deposition, as compared with
control treatments. The appearance of the tissues from the HA-
Table 1 Effect of topical application of the HA-Na on wound contraction and re-epithelization period of excision wound model in rats.
Day Control group (%) bFGF group (%) 1.0% HA-Na group (%)
3 10.4372.11 12.6771.53 14.2271.18
6 30.2272.98 34.2372.16 40.1673.22**
9 72.3372.40 75.4271.17 88.1171.68**
14 88.4173.24 95.3672.51** 98.7671.26**
21 100 100 100
Epithelialization time (days) 17.1672.87 14.3371.03** 14.1671.47**
Values are mean7SEM, n¼8 in each group.
**Po0.01 vs. control group.
Figure 1 Photographic representation of wound contraction on different post-excision days (3, 6, 9, 14 and 21 days), n¼8 in each group.
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control group on the 6th and 14th days after wounding. Poor
collagen ﬁbers and epidermis were present in wounded tissues
from the control group. Histopathological sections of the 6th day
post-wounding showed new skin thickening, granulation tissue
hyperplasia, and small blood vessels in the HA-Na and positive
control groups. Tissues from the control group showed inﬂamma-
tion, thin skin, and signiﬁcantly fewer numbers of ﬁbroblasts as
compared with the HA-Na group (Fig. 2A).
Histopathological sections showed only a few ﬁbroblasts in the HA-
Na and positive control groups on the 14th day post-wounding, with
newly-formed collagen in alignment. Cell differentiation and wound
healing were also apparent. Control wound tissue showed small
numbers of inﬂammatory cells with increased numbers of ﬁbroblasts
forming the epidermal layer. In these tissues, the new collagen
appeared to be disorganized. Masson's trichrome staining showed clear
and distinctly high macrophage and ﬁbroblast density in 1.0% HA-Na
solution treatment. In control group, the arrangement of collagen
bundles was loosely packed and wounds were only moderately cellular
with ﬁbroblasts (Fig. 2A).
On the 6th and 14th days after surgery, CD31-positive expres-
sion was signiﬁcantly higher in the HA-Na group than in the
control and positive control groups. CD31-positive expression was
conﬁned within the scaffold and the contacting zone of the
subcutaneous tissue. Moreover, after 14 days in each group,
different levels of epidermalization appeared and the cells in the
epidermis were highly aggregated (Fig. 2A). MVD was higher in
the HA-Na group, when compared to control and positive control
groups on the 6th and 14th days (Fig. 2B).3.3. Hydroxyproline content
Collagen is present in wound granulation tissue and is produced by
new ﬁbroblasts19,20. The hydroxyproline content of tissue could
reﬂect the collagen synthesis. Hydroxyproline content was sig-
niﬁcantly increased in the HA-Na treated group as compared to the
control group. Although the hydroxyproline content of rb-bFGF
treated group was slightly increased as compared to HA-Na group,
the level was not statistically signiﬁcant (Fig. 3).3.4. Levels of mRNA and protein expression of TGF-β1, TGF-β2
and TGF-β3
The mRNA levels of Tgf-β1, Tgf-β2 and Tgf-β3 were semi-
quantitatively measured using RT-PCR analysis and expressed as
densitometric band intensities of the target gene relative to the
level of the reference mRNA for the housekeeping gene Gapdh.
Results showed that mRNA expression of Tgf-β1 on the 6th day
after wound creation was signiﬁcantly increased in HA-Na group
vs. control, but mRNA expression of Tgf-β1 on the 14th day was
decreased as compared to control group. Moreover, mRNA
expressions of Tgf-β2 and Tgf-β3 6 days after wound creation
had no obvious change in the HA-Na group, whereas mRNA
expressions of Tgf-β2 and Tgf-β3 on the 14th day was increased
as compared to control group (Fig. 4). We further observed
effects of HA-Na on protein expressions of TGF-β1, TGF-β2 and
TGF-β3 after wound creation by western blot analysis, and found
that protein expression patterns were the same as the mRNA
Figure 2 Microscopic view of healing wound tissue and epidermal/dermal re-modeling on different post-excision days (6 and 14 days). (A) Skin
sections show the hematoxylin and eosin (HE) stain (magniﬁcation 100 ), Masson's trichrome (MT) stain (magniﬁcation 100 ), and
microvessel density (MVD) (magniﬁcation 400 ) in control group, bFGF group, and 1.0% HA-Na group. (B) Semi-quantitative description of
MVD. Values are mean7SEM (n¼8). **Po0.01 vs. control group.
Figure 3 Effect of HA-Na on hydroxyproline content. Values are
mean7SEM (n¼8). **Po0.01 vs. control group.
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(Fig. 5).
3.5. Protein expression patterns of Smad-2, -3, -4 and-7
Since intracellular Smad proteins transduce the extracellular TGF-β
signals to the ﬁbroblast nucleus for collagen production, the
expression of Smad-2, -3, -4 and -7 on the 6th and 14th days wasevaluated in wound granulation tissues. Western blot analysis
revealed that expressions of Smad-2, -3 and Smad -4 were increased
in the HA-Na group as compared with controls. However, Smad-7
protein levels diminished (Fig. 6).4. Discussion
HA-Na has been topically used as a wound-healing and anti-
inﬂammatory agent in folk medicine. In the present study, HA-Na
was investigated for cutaneous wound healing in rats to accurately
elucidate its traditional value. Our study demonstrated that HA-Na
has the capacity to promote wound healing in rats via accelerated
wound contraction, elevations in hydroxyproline content. More
importantly, the wound healing effects of HA-Na might be
mediated through the TGF-β/Smad signaling pathway. Therefore,
our results substantiate the utility of HA-Na as a wound-
healing agent.
Wound contraction is the centripetal movement of the healing
edges of a full-thickness wound and healing progress can be
assessed by the periodic measurement of contracting wound
tissue21. The wound contraction values of HA-Na treated group
were signiﬁcantly enhanced as compared to control group. Top-
ical application of HA-Na remarkably accelerated the wound
Figure 4 Effects of HA-Na on mRNA levels of Tgf-β1, Tgf-β2 and Tgf-β3. (A)–(C) Representative RT-PCR analysis of Tgf-β1, Tgf-β2 and Tgf-
β3 mRNA in rats wound tissue on the 6th and 14th days. Gapdh was co-ampliﬁed as an internal standard. The values were normalized to Gapdh
expression and represented as band intensity of Tgf-β1, Tgf-β2 and Tgf-β3 (target gene)/Gapdh. Values are expressed as mean7SEM (n¼8).
**Po0.01 vs. control group.
Figure 5 Effects of HA-Na on protein expressions of TGF-β1, TGF-β2 and TGF-β3. (A) and (B) Protein expressions and quantitation data of
TGF-β1, TGF-β2 and TGF-β3 in rats wound tissues on the 6th and 14th days detected by western blot. The values were normalized to β-actin
expression and represented as band intensity ratio of TGF-β1, TGF-β2 and TGF-β3 (target protein)/β-actin. Values are mean7SEM (n¼8).
*Po0.05, **Po0.01 vs. control group.
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above ﬁnding. Additionally, the histological study demonstrated
that the HA-Na treated group had more rapid re-epithelization and
angiogenesis, compared with the control group. Moreover, bFGF
has also been studied for its role in tissue repair, most commonly
in healing of excisional skin wounds22. In the present study,
compared with the positive group (bFGF group), topical applica-
tion of HA-Na signiﬁcantly promoted wound contraction and re-
epithelization, further suggesting that HA-Na is better than thetraditional drug treatment. In fact, in the preliminary experiment,
the indicated concentrations of HA-Na (0.5%, 1% and 2%)
accelerated the wound contraction in a concentration-dependent
manner (data not shown). Therefore, HA-Na (1%) was topically
administrated in this study.
Collagen, a principal component of connective tissue, plays a
key role in the healing of wounds and provides a structural
framework for the regenerating tissue and the healing process
depends on the regulated production, deposition and their
Figure 6 Effects of HA-Na on protein expressions of Smad-2, -3, -4 and -7. (A) and (B) Protein expressions and quantitation data of Smad-2,
Smad-3, Smad-4 and Smad-7 in rats wound tissues on in rats wound tissues on the 6th and 14th days detected by western blot. The values were
normalized to β-actin expression and represented as band intensity ratio of Smad-2, -3, -4 and -7 (target protein)/β-actin. Values are mean7SEM
(n¼8). *Po0.05, **Po0.01 vs. control group.
Yuanyuan Ji et al.138subsequent maturation23–25. In this study, topical application of
HA-Na evidently enhanced the granulation contains more col-
lagen, ﬁbroblasts and less inﬂammatory cells. Our data also
revealed that HA-Na dramatically increased collagen formation,
because the hydroxyproline content of granulation tissue in HA-Na
treated animal group was obviously higher as compared to control
group. In our opinion, the wound contraction and collagen
synthesis promoting activity of HA-Na could be due to the
accelerated the wound healing activities.
During the stages of wound healing, multiple cell types and
growth factors are required to complete a variety of cellularactivities9,24,26. TGF-β is a key active molecule in wounding
healing and scar formation27. Three subtypes of TGF-β (TGF-β1–
3) play critical roles within different phases of wound healing.
These proteins are of particular important in the late stage of
wound healing. In our experiment, HA-Na up-regulated mRNA
expression of TGF-β1 on Day 6 after wounding and down-
regulated mRNA expression of TGF-β1 on Day 14. It is well
established that TGF-β1 functions as a wound-healing promoting
factor, and excess production of this protein may lead to over-
healing outcomes, such as hypertrophic scarring and keloid28. This
fact may help to understand the down-regulation of TGF-β1 in the
Sodium humate accelerates cutaneous wound healing by activating TGF-β/Smads signaling pathway in rats 139HA-Na group at Day 14. Our study also showed that HA-Na
induces mRNA expressions of TGF-β2 and TGF-β3 on Day 14.
Moreover, we further observed effects of HA-Na on protein
expressions of TGF-β1, TGF-β2 and TGF-β3 after wound creation
by western blot analysis, and protein examination supported the
above ﬁndings, suggesting that the wound healing effect of HA-Na
might be mediated through TGF-β signaling pathway.
The TGF-β-mediated signaling pathway is believed to be closely
associated with wound healing and scar formation29. Smad proteins
function as intracellular signaling mediators of TGF-β family
members30. The present study detected that HA-Na topical
application up-regulated expression of Smad-2, -3 and -4 proteins,
whereas the expression of Smad-7, the inhibitory protein, was
down-regulated. The diminished level of inhibitory Smad-7 also
ampliﬁed the effect of HA-Na in wound healing, further suggesting
that HA-Na might activate TGF-β/Smad signaling pathway. So far,
this study has used excisional wounds generated in rats followed
by measurement of TGF-β/Smad signaling pathway components.
The present results found that the wound healing promoting
activity of HA-Na could be associated with the TGF-β/Smad
signaling pathway. However, further studies using TGF-β isoform-
speciﬁc neutralizing antibodies and adenoviral delivery of Smad-2,
Smad-3, and/or Smad-4 at the stages of wound healing in rat model
are possible avenues of future research to further elucidate the
regulation of HA-Na on TGF-β/Smad signaling pathway.
Targeting the TGF-β/Smad signaling pathway using therapeutic
agents to improve wound healing and/or reduce scarring has been
successful in pre-clinical studies. CAT-192 is a human monoclonal
antibody that neutralizes TGF-β1 and was shown to improve
corneal wound healing in bovine organ cultures by promoting re-
epithelialization31. As an example, peptide 144 (P144) is a 14-mer
peptide from human betaglycan that was designed as a TGF-β1
inhibitor and has shown efﬁcacy in reducing ﬁbrosis in different
animal models32,33. In addition, Smad-3 antisense oligonucleotides
accelerated wound healing and reduced scarring in a mouse
excisional wound model34. Since the role of TGF-β/Smad signal-
ing pathway in wound healing has been well characterized, it is
feasible to explore the effect of HA-Na on wound healing and the
molecular mechanisms underlying the TGF-β/Smad signaling
pathway.
HA-Na, an anti-inﬂammatory, anti-microbial, and anti-ulcer
drug, is thought to have the broadest spectrum of effects. The
use of HA-Na in treating burns and wounds is an especially
important mode to improve healing, as well as to reduce the cost of
therapy. Although the present study is promising, it remains to be
seen whether HA-Na will be of clinical use, as HA-Na have yet
been screened in phase I clinical trials for safety and tolerability.5. Conclusions
HA-Na has the capacity to promote wound healing in rat model
via accelerated wound contraction, higher hydroxyproline content
and improved the level of tissue healing. More importantly, the
wound healing effect of HA-Na might be mediated through the
TGF-β/Smad signaling pathway. HA-Na may be used as a future
novel wound-healing agent.
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